Abstract
Generation 4 polyamidoamine (PAMAM) and, for the first time, hyperbranched poly(ethylene imine) or polyglycerol dendrimers have been loaded with Gd3+ chelates, and the macromolecular adducts have been studied in vitro and in vivo with regard to MRI contrast agent applications. The Gd3+ chelator was either a tetraazatetracarboxylate DOTA-pBn4− or a tetraazatricarboxylate monoamide DO3A-MA3− unit. The water exchange rate was determined from a 17O NMR and 1H Nuclear Magnetic Relaxation Dispersion study for the corresponding monomer analogues [Gd(DO3A-AEM)(H2O)] and [Gd(DOTA-pBn-NH2)(H2O)]− (k 298ex = 3.4 and 6.6 × 106 s−1, respectively), where H3DO3A-AEM is {4-[(2-acetylaminoethylcarbamoyl)methyl]-7,10-bis(carboxymethyl-1,4,7,10-tetraazacyclododec-1-yl)}-acetic acid and H4DOTA-pBn-NH2 is 2-(4-aminobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid. For the macromolecular complexes, variable-field proton relaxivities have been measured and analyzed in terms of local and global motional dynamics by using the Lipari–Szabo approach. At frequencies below 100 MHz, the proton relaxivities are twice as high for the dendrimers loaded with the negatively charged Gd(DOTA-pBn)− in comparison with the analogous molecule bearing the neutral Gd(DO3A-MA). We explained this difference by the different rotational dynamics: the much slower motion of Gd(DOTA-pBn)−-loaded dendrimers is likely related to the negative charge of the chelate which creates more rigidity and increases the overall size of the macromolecule compared with dendrimers loaded with the neutral Gd(DO3A-MA). Attachment of poly(ethylene glycol) chains to the dendrimers does not influence relaxivity. Both hyperbranched structures were found to be as good scaffolds as regular PAMAM dendrimers in terms of the proton relaxivity of the Gd3+ complexes. The in vivo MRI studies on tumor-bearing mice at 4.7 T proved that all dendrimeric complexes are suitable for angiography and for the study of vasculature parameters like blood volume and permeability of tumor vessels.
Similar content being viewed by others
Abbreviations
- CA:
-
Contrast agent
- DCE:
-
Dynamic contrast enhanced
- DTPA:
-
Diethylenetriaminpentaacetic acid
- EPR:
-
Electron paramagnetic resonance
- FLASH:
-
Fast low-angle shot
- FOV:
-
Field of view
- G4:
-
Generation 4
- H3DO3A-AEM:
-
{4-[(2-Acetylaminoethylcarbamoyl)methyl]-7,10-bis(carboxymethyl-1,4,7,10-tetraazacyclododec-1-yl)}-acetic acid
- H4DOTA-pBn-NH2 :
-
2-(4-Aminobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
- H4DOTA-pBn-SCN is:
-
2-(4-Isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
- H4DOTA-NHS:
-
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid mono(N-hydroxysuccinimide ester)
- HB:
-
Hyperbranched
- HEPES:
-
N-(2-Hydroxyethyl)piperazine-N′-ethanesulfonic acid
- ICP:
-
Inductively coupled plasma
- IR:
-
Inversion recovery
- MA:
-
Monoamide
- mPEG-SPA:
-
Methoxypoly(ethylene glycol)–succinimidyl propionate
- MRI:
-
Magnetic resonance imaging
- NMRD:
-
Nuclear Magnetic Relaxation Dispersion
- PAMAM:
-
Polyamidoamine
- PEG:
-
Poly(ethylene glycol)
- PEI:
-
Poly(ethylene imine)
- PG:
-
Polyglycerol
- RARE:
-
Rapid acquisition and relaxation enhancement, fast spin echo MRI method
- ROI:
-
Region of interest
- TE:
-
Echo time
- TR:
-
Repetition time
- ZFS:
-
Zero-field splitting
References
Edelman RR, Hesselink JR, Zlatkin MB (1996) MRI: clinical magnetic resonance imaging. Saunders, Philadelphia
Caravan P, Ellison JJ, McMurry TJ, Lauffer RB (1999) Chem Rev 99:2293
Tóth É, Merbach AE (eds) (2001) The chemistry of contrast agents in medical magnetic resonance imaging. Wiley, Chichester
Boas U, Heegaard Peter MH (2004) Chem Soc Rev 33:43
Stiriba S-E, Frey H, Haag R (2002) Angew Chem Int Ed Engl 41:1329
Qiu LY, Bae YH (2006) Pharm Res 23:1
Wiener EC, Brechbiel MW, Brothers H, Magin RL, Gansow OA, Tomalia DA, Lauterbur PC (1994) Magn Reson Med 31:1
Bryant LH Jr, Brechbiel MW, Wu C, Bulte JWM, Herynek V, Frank JA (1999) J Magn Reson Imaging 9:348
Margerum LD, Campion BK, Koo M, Shargill N, Lai J-J, Marumoto A, Sontum PC (1997) J Alloys Compd 249:185
Tóth É, Pubanz D, Vauthey S, Helm L, Merbach AE (1996) Chem Eur J 2:1607
Konda SD, Aref M, Brechbiel M, Wiener EC (2000) Invest Radiol 35:50
Rudovsky J, Hermann P, Botta M, Aime S, Lukes I (2005) Chem Commun 2390
Dong Q, Hurst DR, Weinmann HJ, Chenevert TL, Londy FJ, Prince MR (1998) Invest Radiol 33:699
Venditto VJ, Regino CAS, Brechbiel MW (2005) Mol Pharm 2:302
Esfand R, Tomalia DA (2001) Drug Discov Today 6:427
Voit BI (2003) C R Chimie 6:821
Fernandes EGR, De Queiroz AAA, Abraham GA, Roman JS (2006) J Mater Sci Mater Med 17:105
Lipari G, Szabo A (1982) J Am Chem Soc 104:4546
Lipari G, Szabo A (1982) J Am Chem Soc 104:4559
Krämer M, Stumbé J-F, Grimm G, Kaufmann B, Krüger U, Weber M, Haag R (2004) ChemBioChem 5:1081
Koç F, Wyszogrodzka M, Eilbracht P, Haag R (2005) J Org Chem 70:2021
Ammann C, Meier P, Merbach AE (1982) J Magn Reson 46:319
Hugi AD, Helm L, Merbach AE (1985) Helv Chim Acta 68:508
Yerly F (1999) Visualiseur 2.3.4. Institute of Molecular and Biological Chemistry, University of Lausanne, Lausanne
Yerly F (1999) Optimiseur 2.3.4. Institute of Molecular and Biological Chemistry, University of Lausanne, Lausanne
Haase A, Matthaei D, Bartkowski R, Duhmke E, Leibfritz D (1989) J Comput Assist Tomogr 13:1036
Jivan A, Horsfield MA, Moody AR, Cherryman GR (1997) J Magn Reson 127:65
Kobayashi H, Kawamoto S, Saga T, Sato N, Hiraga A, Ishimori T, Konishi J, Togashi K, Brechbiel MW (2001) Magn Res Med 46:781
Tóth É, Helm L, Merbach AE (2001) In: Tóth É, Merbach AE (eds) The chemistry of contrast agents in medical magnetic resonance imaging. Wiley, Chichester, pp 45–120
Kowalewski J, Kruk D, Parigi G (2005) Adv Inorg Chem 57:42
Helm L (2006) Prog NMR Spectrosc 49:45
Belorizky E, Fries PH (2004) Phys Chem Chem Phys 6:2341
Helm L, Tóth É, Merbach AE (2003) In: Sigel A, Sigel H (eds) Metal ions in biological systems, vol 40. Marcel Dekker, New York
Laurent S, Houzé S, Guérit N, Muller RN (2000) Helv Chim Acta 83:394
Vander Elst L, Maton F, Laurent S, Seghi F, Chapelle F, Muller RN (1997) Magn Reson Med 38:604
Laurent S, Botteman F, Vander Elst L, Muller RN (2004) Eur J Inorg Chem 3:463
Woods M, Kovacs Z, Zhang S, Sherry AD (2003) Angew Chem Int Ed Engl 42:5889
Laus S, Ruloff R, Tóth É, Merbach AE (2003) Chem Eur J 9:3555
Tóth É, Helm L, Kellar KE, Merbach AE (1999) Chem Eur J 5:1202
Nicolle GM, Tóth É, Eisenwiener KP, Mäcke HR, Merbach AE (2002) J Biol Inorg Chem 7:757
Laus S, Sour A, Ruloff R, Tóth É, Merbach AE (2005) Chem Eur J 11:3064
Nicolle GM, Tóth É, Schmitt-Willich H, Radüchel B, Merbach AE (2002) Chem Eur J 8:1040
Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, Jayson GC, Judson IR, Knopp MV, Maxwell RJ, McIntyre D, Padhani AR, Price P, Rathbone R, Rustin GJ, Tofts PS, Tozer GM, Vennart W, Waterton JC, Williams SR, Workman P (2005) Br J Cancer 92:1599
Burai L, Tóth É, Bazin H, Benmelouka M, Jászberényi Z, Merbach AE (2006) Dalton Trans 629
Acknowledgements
We thank the Swiss National Science Foundation and the Swiss State Secretariat for Education and Research (SER) for financial support. This work was performed in the frame of the EU COST Actions D18 “Lanthanide chemistry for diagnosis and therapy” and D38 “Metal-based systems for molecular imaging applications” and the European-founded EMIL program (LSCH-2004–503569).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Jászberényi, Z., Moriggi, L., Schmidt, P. et al. Physicochemical and MRI characterization of Gd3+-loaded polyamidoamine and hyperbranched dendrimers. J Biol Inorg Chem 12, 406–420 (2007). https://doi.org/10.1007/s00775-006-0197-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-006-0197-3